JESSICA HILL: Open Payments
NPI 1578953287 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 9 payments from 6 companies in 2025. Trend: 2023 $694 · 2024 $261 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $38 |
| Amgen Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: Veozah, EVENITY, REXULTI, VRAYLAR, AIRSUPRA, CAPLYTA, BREZTRI.
Industry payments across MD — which companies pay providers there.
